Oxidized phospholipids induce type VIII collagen expression and vascular smooth muscle cell migration

Circulation Research

Volumn 104, Issue 5, 2009, Pages 609-618

  Cherepanova, Olga A ^a   Pidkovka, Nataliya A ^c   Sarmento, Olga F ^a   Yoshida, Tadashi ^a   Gan, Qiong ^a   Adiguzel, Eser ^d   Bendeck, Michelle P ^d   Berliner, Judith ^e   Leitinger, Norbert ^b   Owens, Gary K ^a  

^a UNIVERSITY OF VIRGINIA   (United States)

^b UNIVERSITY OF VIRGINIA   (United States)

^c VANDERBILT UNIVERSITY MEDICAL CENTER   (United States)

^d UNIVERSITY OF TORONTO   (Canada)

^e UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Klf4; PEIPC; PGPC; POVPC; Type VIII collagen; Vascular smooth muscle cell migration

Indexed keywords

1 PALMITOYL 2 (5 OXOVALEROYL) SN GLYCERO 3 PHOSPHORYLCHOLINE; COLLAGEN TYPE 8; KRUPPEL LIKE FACTOR 4; LOW DENSITY LIPOPROTEIN; MESSENGER RNA; PHOSPHOLIPID; PHOSPHORYLCHOLINE; SMALL INTERFERING RNA; TRANSCRIPTION FACTOR SP1; UNCLASSIFIED DRUG; 1 PALMITOYL 2 GLUTAROYL SN GLYCERO 3 PHOSPHORYLCHOLINE; 1-PALMITOYL-2-(5-OXOVALEROYL)-SN-GLYCERO-3-PHOSPHORYLCHOLINE; 1-PALMITOYL-2-GLUTAROYL-SN-GLYCERO-3-PHOSPHORYLCHOLINE; APOLIPOPROTEIN E; ETHER PHOSPHOLIPID; KRUPPEL LIKE FACTOR; OXIDIZED L ALPHA 1 PALMITOYL 2 ARACHIDONOYL SN GLYCERO 3 PHOSPHORYLCHOLINE; OXIDIZED LOW DENSITY LIPOPROTEIN; OXIDIZED-L-ALPHA-1-PALMITOYL-2-ARACHIDONOYL-SN-GLYCERO-3-PHOSPHORYLCHOLINE; PHOSPHATIDYLCHOLINE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; ATHEROSCLEROSIS; CAROTID ARTERY; CELL CULTURE; CELL DIFFERENTIATION; CELL MIGRATION; CONTROLLED STUDY; ENDOTHELIUM CELL; EXTRACELLULAR MATRIX; GENE EXPRESSION; IMMUNOPRECIPITATION; IN VIVO STUDY; MACROPHAGE; MALE; MARKER GENE; MOUSE; NONHUMAN; OXIDATION; PHENOTYPE; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN EXPRESSION; RAT; VASCULAR SMOOTH MUSCLE; ANIMAL; AORTA; C57BL MOUSE; CELL MOTION; GENETIC TRANSFECTION; GENETICS; METABOLISM; MOUSE MUTANT; OXIDATION REDUCTION REACTION; PROMOTER REGION; RNA INTERFERENCE; SMOOTH MUSCLE FIBER; TIME; UPREGULATION;

ANIMALS; AORTA; APOLIPOPROTEINS E; CAROTID ARTERIES; CELL MOVEMENT; CELLS, CULTURED; COLLAGEN TYPE VIII; KRUPPEL-LIKE TRANSCRIPTION FACTORS; LIPOPROTEINS, LDL; MALE; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MUSCLE, SMOOTH, VASCULAR; MYOCYTES, SMOOTH MUSCLE; OXIDATION-REDUCTION; PHENOTYPE; PHOSPHATIDYLCHOLINES; PHOSPHOLIPID ETHERS; PHOSPHOLIPIDS; PROMOTER REGIONS, GENETIC; RATS; RNA INTERFERENCE; RNA, MESSENGER; RNA, SMALL INTERFERING; SP1 TRANSCRIPTION FACTOR; TIME FACTORS; TRANSFECTION; UP-REGULATION;

EID: 63649134360     PISSN: 00097330     EISSN: 15244571     Source Type: Journal    
DOI: 10.1161/CIRCRESAHA.108.186064     Document Type: Article

References (35)

1. Berliner J, Leitinger N, Watson A, Huber J, Fogelman A, Navab M. Oxidized lipids in atherogenesis: Formation, destruction and action. Thromb Haemost. 1997;78:195-199.
2. Chatterjee S. Role of oxidized human plasma low-density lipoproteins in atherosclerosis - effects on smooth-muscle cell-proliferation. Mol Cell Biochem. 1992;111:143-147.
3. Furnkranz A, Schober A, Bochkov VN, Bashtrykov P, Kronke G, Kadl A, Binder BR, Weber C, Leitinger N. Oxidized phospholipids trigger atherogenic inflammation in murine arteries. Arterioscler Tromb Vasc Biol. 2005;25:633-638.
4. Subbanagounder G, Leitinger N, Schwenke DC, Wong JW, Lee H, Rizza C, Watson A, Faull K, Fogelman A, Berliner J. Determinants of bioactivity of oxidized phospholipids: specific oxidized fatty acyl groups at the sn-2 position. Arterioscler Tromb Vasc Biol. 2000;20: 2248-2254.
5. Watson AD, Leitinger N, Navab M, Faull KF, Horkko S, Witztum JL, Palinski W, Schwenke D, Salomon RG, Sha W, Subbanagounder G, Fogelman AM, Berliner JA. Structural identification by mass spec-trometry of oxidized phospholipids in minimally oxidized low density lipoprotein that induce monocyte/endothelial interactions and evidence for their presence in vivo. J Biol Chem. 1997;272: 13597-13607.
6. Owens GK, Kumar MS, Wamhoff BR. Molecular regulation of vascular smooth muscle cell differentiation in development and disease. Physiol Rev. 2004;84:767-801.
7. Pidkovka N, Cherepanova OA, Yoshida T, Alexander M, Deaton RA, Thomas J, Leitinger N, Owens G. Oxidized phospholipids induce phe-notypic switching of vascular smooth muscle cells in vivo and in vitro. Circ Res. 2007;101:792-801.
8. Heeneman S, Cleutjens JP, Faber BC, Creemers EE, van Suylen RJ, Lutgens E, Cleutjens KB, Daemen MJ. The dynamic extracellular matrix: intervention strategies during heart failure and atherosclerosis. J Pathol. 2003;200:516-525.
9. Stegemann JP, Hong H, Nerem RM. Mechanical, biochemical, and extra-cellular matrix effects on vascular smooth muscle cell phenotype. J Appl Physiol. 2005;98:2321-2327.
10. Bauters C, Marotte F, Hamon M, Oliviero P, Farhadian F, Robert V, Samuel JL, Rappaport L. Accumulation of fetal fibronectin messenger-RNAs after balloon denudation of rabbit arteries. Circulation. 1995;92:904-911.
11. Glukhova MA, Frid MG, Shekhonin BV, Vasilevskaya TD, Grunwald J, Saginati M, Koteliansky VE. Expression of extra domain-A fibronectin sequence in vascular smooth-muscle cells is phenotype dependent. J Cell Biol. 1989;109:357-366.
12. Plenz G, Dorszewski A, Breithardt G, Robenek H. Expression of type VIII collagen after cholesterol diet and injury in the rabbit model of atherosclerosis. Arterioscler Tromb Vasc Biol. 1999;19:1201-1209.
13. Yasuda O, Zhang SH, Miyamoto Y, Maeda N. Differential expression of the alpha 1 type VIII collagen gene by smooth muscle cells from atherosclerotic plaques of apolipoprotein-E-deficient mice. J Vasc Res. 2000; 37:158-169.
14. Jimi S, Saku K, Uesugi N, Sakata N, Takebayashi S. Oxidized low-density-lipoprotein stimulates collagen production in cultured arterial smooth-muscle cells. Atherosclerosis. 1995;116:15-26.
15. Cole AL, Subbanagounder G, Mukhopadhyay S, Berliner JA, Vora DK. Oxidized phospholipid-induced endothelial cell/monocyte interaction is mediated by a cAMP-dependent R-Ras/PI3-kinase pathway. Arterioscler Tromb Vasc Biol. 2003;23:1384-1390.
16. Korsching E, Rauterberg J. Generation of type VIII collagen-specific antibodies. J Immunol Methods. 1995;188:51-62.
17. Benya PD, Shaffer JD. Dedifferentiated chondrocytes reexpress the differentiated collagen phenotype when cultured in agarose gels. Cell. 1982; 30:215-224.
18. Sage H, Balian G, Vogel AM, Bornstein P. Type VIII collagen -synthesis by normal and malignant cells in culture. Lab Invest. 1984; 50:219-231.
19. Shields JM, Yang VM. Identification of the DNA sequence that interacts with the gut-enriched Kruppel-like factor. Nucleic Acids Res. 1998;26: 796-802.
20. Katz JP, Perreault N, Goldstein BG, Lee CS, Labosky PA, Yang VW, Kaestner KH. The zinc-finger transcription factor Klf4 is required for terminal differentiation of goblet cells in the colon. Development. 2002; 129:2619-2628.
21. Chen ZY, Rex S, Tseng CC. Kruppel-like factor 4 is transactivated by butyrate in colon cancer cells. J Nutr. 2004;134:792-798.
22. Adiguzel E, Hou GP, Mulholland D, Hopfer U, Fukai N, Olsen B. Bendeck MP. Migration and growth are attenuated in vascular smooth muscle cells with type VIII collagen-null allels. Arterioscler Tromb Vasc Biol. 2006;26:56-61.
23. Hou GP, Mulholland D, Gronska MA, Bendeck MP. Type VIII collagen stimulates smooth muscle cell migration and matrix metal-loproteinase synthesis after arterial injury. Am J Pathol. 2000;156: 467-476.
24. Bendeck MP, Regenass S, Tom WD, Giachelli CM, Schwartz SM, Hart C, Reidy MA. Differential expression of alpha(1) type VIII collagen in injured platelet-derived growth factor-BB-stimulated rat carotid arteries. Circ Res. 1996;79:524-531.
25. Sibinga NES, Foster LC, Hsieh CM, Perrella MA, Lee WS, Endege WO, Sage EH, Lee ME, Haber E. Collagen VIII is expressed by vascular smooth muscle cells in response to vascular injury. Circ Res. 1997;80: 532-541.
26. Plenz GAM, Deng MC, Robenek H, Volker W. Vascular collagens: spotlight on the role of type VIII collagen in atherogenesis. Atherosclerosis. 2003; 166:1-11.
27. Plenz G, Koenig C, Reichenberg S, Robenek H. Colony stimulating factors modulate the transcription of type VIII collagen in vascular smooth muscle cells. Atherosclerosis. 1999;144:25-32.
28. Plenz G, Dorszewski A, Volker W, Ko YS, Severs NJ, Breithardt G, Robenek H. Cholesterol-induced changes of type VIII collagen expression and distribution in carotid arteries of rabbit. Arterioscler Tromb Vasc Biol. 1999;19:2395-2404.
29. Gounopoulos P, Merki E, Hansen LF, Choi SH, Tsimikas S. Antibodies to oxidized low density lipoprotein: epidemiological studies and potential clinical applications in cardiovascular disease. Minerva Cardioangiol. 2007;55:821-837.
30. Adam PJ, Regan CP, Hautmann MB, Owens GK. Positive- and negative-acting Kruppel-like transcription factors bind a transforming growth factor beta control element required for expression of the smooth muscle cell differentiation marker SM22 alpha in vivo. J Biol Chem. 2000;275: 37798-37806.
31. Liu Y, Sinha S, McDonald OG, Shang Y, Hoofnagle MH, Owens KG. Kruppel-like factor 4 abrogates myocardin-induced activation of smooth muscle gene expression. J Biol Chem. 2005;280:9719-9727.
32. Yoshida T, Kaestner KH, Owens GK. Conditional deletion of Kruppel-like factor 4 delays downregulation of smooth muscle cell differentiation markers but accelerates neointimal formation following vascular injury. Circ Res. 2008;102:1548-1557.
33. Black AR, Black JD, Azizkhan-Clifford J. Sp1 and kruppel-like factor family of transcription factors in cell growth regulation and cancer. J Cell Physiol. 2001;188:143-160.
34. Leitinger N, Tyner TR, Oslund L, Rizza C, Subbanagounder G, Lee H, Shih PT, Mackman N, Tigyi G, Territo MC, Berliner JA, Vora DK. Structurally similar oxidized phospholipids differentially regulate endothelial binding of monocytes and neutrophils. Proc Natl Acad Sci U S A. 1999;96:12010-12015.
35. Rocnik EF, Chan BMC, Pickering JG. Evidence for a role of collagen synthesis in arterial smooth muscle cell migration. J Clin Invest. 1998; 101:1889-1898.